Carisma Therapeutics, Inc. (CARM)
NASDAQ: CARM · Real-Time Price · USD
1.030
-0.080 (-7.21%)
At close: Nov 7, 2024, 4:00 PM
1.080
+0.050 (4.85%)
After-hours: Nov 7, 2024, 6:07 PM EST
Carisma Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Nov '24 Nov 7, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 43 | 118 | - | - | - |
| Enterprise Value | 8 | 27 | - | - | - |
| Last Close Price | 1.11 | 2.93 | - | - | - |
| PE Ratio | - | -1.13 | - | - | - |
| PS Ratio | 2.19 | 7.93 | - | - | - |
| PB Ratio | 128.10 | 4.46 | - | - | - |
| P/FCF Ratio | -0.83 | -1.44 | - | - | - |
| P/OCF Ratio | -0.83 | -1.46 | - | - | - |
| EV/Sales Ratio | 0.38 | 1.80 | - | - | - |
| EV/EBITDA Ratio | -0.17 | -0.31 | - | - | - |
| EV/EBIT Ratio | -0.17 | -0.30 | - | - | - |
| EV/FCF Ratio | -0.16 | -0.33 | - | - | - |
| Debt / Equity Ratio | 10.44 | 0.12 | -1.15 | 0.10 | 0.07 |
| Debt / FCF Ratio | -0.05 | -0.04 | -4.11 | -0.07 | -0.13 |
| Asset Turnover | 0.22 | 0.18 | 0.18 | - | - |
| Quick Ratio | 2.81 | 4.88 | 2.64 | 3.71 | 9.12 |
| Current Ratio | 3.25 | 5.06 | 2.78 | 3.87 | 9.34 |
| Return on Equity (ROE) | -216.21% | - | - | -107.08% | - |
| Return on Assets (ROA) | -49.37% | -68.59% | -65.24% | -54.30% | - |
| Return on Capital (ROIC) | -124.87% | -317.29% | -206.73% | -61.99% | - |
| Earnings Yield | -163.10% | -73.47% | - | - | - |
| FCF Yield | -172.12% | -69.61% | - | - | - |
| Buyback Yield / Dilution | -183.73% | -1475.33% | -96.30% | -1.95% | - |
| Total Shareholder Return | -183.73% | -1475.33% | -96.30% | -1.95% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.